S-phase cell-specific modification by gemcitabine of PFGE-analyzed radiation-induced DNA fragmentation and rejoining

International Journal of Radiation Biology

Volumn 84, Issue 9, 2008, Pages 770-777

  Jensen, Alexandra ^a   Debus, Jürgen ^a   Weber, Klaus Josef ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

DSB; Gemcitabine; PFGE; Radiation; S phase

Indexed keywords

DNA FRAGMENT; DOUBLE STRANDED DNA; GEMCITABINE;

ARTICLE; CANCER CELL; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL POPULATION; CELL STIMULATION; COLON CARCINOMA; CONTROLLED STUDY; DNA FRAGMENTATION; DNA STRAND BREAKAGE; DNA STRUCTURE; ELECTROPORATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IONIZING RADIATION; MISMATCH REPAIR; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RADIATION DOSE; RADIOSENSITIZATION; TREATMENT DURATION;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DEOXYCYTIDINE; DNA; DNA FRAGMENTATION; DNA REPAIR; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMANS; S PHASE; SENSITIVITY AND SPECIFICITY;

EID: 52949148187     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.1080/09553000802317752     Document Type: Article

References (34)

1. Blöcher D, Kunhi M. 1990. DNA double-strand break analysis by CHEF electrophoresis. International Journal of Radiation Biology 58:23-34.
2. Chen M, Hough AM, Lawrence TS. 2000. The role of p53 in gemcitabine-mediated cytotoxicity and radiosensitization. Cancer Chemotherapy Pharmacology 45:369-374.
3. Dewey WC, Wong RS, Albright N. 1997. Pulsed-field gel electrophoretic migration of DNA broken by X irradiation during DNA synthesis: Experimental results compared with Monte Carlo calculations. Radiation Research 148:413-420.
4. Elliott B, Jasin M. 2001. Repair of double-strand breaks by homologous recombination in mismatch repeir-defective mammalian cells. Molecular and Cellular Biology 21:2671-2682.
5. Ewald B, Sampath D, Plunkett W. 2007. H2AX phosphorylation marks gemcitabine-induced stalled replication forks and their collapse upon S-phase checkpoint abrogation. Molecular Cancer Therapeutics 6:1239-1248.
6. Flanagan SA, Robinson BW, Krokosky CM, Shewach DS. 2007. Mismatched nucleotides as the lesions responsible for radiosensitization with gemcitabine: A new paradigm for antimetabolite radiosensitizers. Molecular Cancer Therapeutics 6:1858-1868.
7. Flentje M, Asadpour B, Latz D, Weber KJ. 1993. Sensitivity of neutral filter elution but not PFGE can be modified by non-DSB chromatin damage. International Journal of Radiation Biology 63:715-724.
8. Gauter B, Zlobiskaya O, Weber KJ. 2002. Rejoining of radiation-induced DNA double-strand breaks: Pulsed-field electrophoresis analysis of fragment size distributions after incubation for repair. Radiation Research 157:721-733.
9. Grégoire V, Beauduin M, Rosier J-F, Bruniaux M, De Coster B, Octave-Prignot M, Scalliet P. 1998. Radiosensitization of mouse sarcoma cells by fludarabine (F-ara-A) or gemcitabine (dFdC), two nucleoside analogues, is not mediated by an increased induction or a repair inhibition of DNA double-strand breaks as measured by pulsed-field gel electrophoresis. International Journal of Radiation Biology 73:511-520.
10. Grégoire V, Hittelmann WN, Rosier JF, Milas L. 1999. Chemoradiotherapy: Radiosenitizing nucleoside analogues (review). Oncology Reports 6:949-957.
11. Huang P, Chubb S, Hertel LW, Grindey GB, Plunkett W. 1991. Action of 2′,2′-difluorodeoxycytidine on DNA synthesis. Cancer Research 51:6110-6117.
12. Iliakis GE, Cicilioni O, Metzger L. 1991. Measurement of DNA double-strand breaks in CHO cells at various stages of the cell cycle using pulsed field gel electrophoresis: calibration by means of 125I decay. International Journal of Radiation Biology 59:343-357.
13. Jeggo PA. 1998. Identification of genes involved in repair of DNA double strand breaks in mammalian cells, Radiation Research 150:S80-91.
14. Jiricny J. 2006. The multifaceted mismatch-repair system. Nature Reviews Molecular Cell Biology 7:335-346.
15. Kanaar R, Hoejmakers JH, van Gent DC. 1998. Molecular mechanisms of DNA double strand break repair. Trends in Cell Biology 8:483-489.
16. Latz D, Dewey WC, Flentje M, Lohr F, Wenz F, Weber KJ. 1996. Migration patterns in pulsed-field electrophoresis of DNA restriction fragments from log-phase mammalian cells after irradiation and incubation for repair. International Journal of Radiation Biology 70:637-646.
17. Latz D, Fleckenstein K, Eble M, Blatter J, Wannenmacher M, Weber KJ. 1998. Radiosensitizing potential of Gemcitabine (2′,2′-Difluoro- 2′-Deoxycytidine) within the cell cycle in vitro. Intenational Journal of Radiation Oncology Biology Physics 41:875-882.
18. Lawrence TS, Eisbruch A, McGinn CJ, Fields MT, Shewach DS. 1999. Radiosensitization by gemcitabine. Oncology 13:55-60.
19. Modrich P, Lahue R. 1996. Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Annual Reviews in Biochemistry 65:101-133.
20. Mose S, Karapetian M, Jüling-Pohlit L, Taborski B, Damrau M, Ramm U, Rahn A, Böttcher HD. 2000. Radiation enhancement of Gemcitabine in two human squamous cell carcinoma cell lines. Anticancer Research 20:401-406.
21. Ostruszka L, Shewach DS. 2000. The role of cell cycle progression in radiosensitization by 2′,2′-difluoro-2′-deoxycytidine. Cancer Research 60:6080-6088.
22. Plunkett W, Huang P, Xu Y, Grunewald R, Gandhi V. 1995. Gemcitabine: metabolism, mechanisms of action, and self-potentiation. Seminars in Oncology 22:3-10.
23. Robinson BW, Im MM, Ljungman M, Praz F, Shewach DS. 2003. Enhanced radiosensitization with gemcitabine in mismatch repair-deficient HCT116 cells. Cancer Research 63:6935-6941.
24. Robinson BW, Ostruszka L, Im MM, Shewach DS. 2004. Promising combination therapies with gemcitabine. Seminars in Oncology 31:2-12.
25. Rosier J-F, Michaux L, Ameye G, Cedervall B, Libouton J-M, Octave-Prignot M, Verellen-Dumoulin C, Scalliet P, Gregoire V. 2003. The radioenhancement of two human head and neck squamous cell carcinomas by 2′,2′- difluorodeoxycytidine (gemcitabine; dFdC) is mediated by an increase in radiation-induced residual chromosome aberrations but not residual DNA DSBs. Mutation Research 527:15-26.
26. Rothkamm K, Krüger I, Thomson LH, Löbrich M. 2003. Pathways of DNA double-strand break repair during the mammalian cell cycle. Molecular and Cellular Biology 23:5706-5715.
27. Shewach DS, Hahn TM, Chang E, Hertel LW, Lawrence TS. 1994. Metabolism of 2′,2′-difluoro-2′-deoxycytidine and radiation sensitization of human colon carcinoma cells. Cancer Research 54:3218-3223.
28. Toschi L, Finochiaro G, Bartolini S, Gioia V, Capuzzo F. 2005. Role of gemcitabine in cancer therapy. Future Oncology 1:7-17.
29. Van Bree C, Rodermond HM, de Vos J, Haveman J, Franken NAP. 2005. Mismatch repair proficiency is not required for radioenhancement by gemcitabine. International Journal of Radiation Oncology Biology Physics 62:1504-1509.
30. Van Moorsel CJ, Smid K, Voorn DA, Bergmann AM, Pinedo HM, Peters GJ. 2003. Effect of gemcitabine and cis-platinum combinations on ribonucleotide and deoxynucleotide pools in ovarian cancer cell lines. International Journal of Oncology 22:201-207.
31. Van Putten JWG, Groen HJM, Smid K, Peters GJ, Kampinga HH. 2001. End-joining deficiency and radiosensitization induced by gemcitabine. Cancer Research 61:1585-1591.
32. Wachters FM, Van Putten JWG, Maring JG, Zdziencka MZ, Groen HJM, Kampinga HH. 2003. Selective targeting of homologous DNA recombination repair by gemcitabine. International Journal of Radiation Oncology Biology Physics 57:553-562.
33. Weiss C, Grabenbauer GG, Sauer R, Distel L. 2003. Significant increase in residual DNA damage as a possible mechanism of radiosensitization by gemcitabine. Strahlentherapie und Onkologie 179:93-98.
34. Wheeler JMD, Beck NE, Kim HC, Tomlinson IPM, Mortensen NJMcC, Bodmer WF. 1999. Mechanisms of inactivation of mismatch repair genes in human colorectal cancer celllines: The predominant role of hMLH1. Proceedings of the National Academy of Sciences USA 96:10296-10301.